Vyne Therapeutics Inc (VYNE)

Finanzdaten der Vyne Therapeutics Inc-Aktie (VYNE)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	28.95% 0.098	0.076	0.114	0.135	0.099
Operating Expenses	8.25% 7.478	6.908	6.348	10.45	5.974
Benefits Costs and Expenses	1.78% 6.339	6.228	6.185	10.17	5.711
Costs And Expenses	8.25% 7.478	6.908	6.348	10.45	5.974
Operating Income/Loss	8.02% -7.38	-6.832	-6.234	-10.32	-5.875
Income/Loss From Continuing Operations Before Tax	1.45% -6.241	-6.152	-6.071	-10.04	-5.612
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	1.45% -6.241	-6.152	-6.071	-10.04	-5.612
Income/Loss From Discontinued Operations, Net Of Tax	77.78% -0.008	-0.036	-0.513	-0.02	-0.01
Net Income/Loss	0.99% -6.249	-6.188	-6.584	-10.06	-5.622
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	508.13% 42.58	7.002	3.282	3.274	3.255
Diluted Average Shares	508.13% 42.58	7.002	3.282	3.274	3.255
Basic Earnings Per Share	103.71% -0.15	4.04	-2.01	-3.09	-1.74
Diluted Earnings Per Share	103.71% -0.15	4.04	-2.01	-3.09	-1.74
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-